Kintor Pharmaceutical Limited (HKG:9939)

Kintor Pharmaceutical Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	695	420	729	4,408	4,767	3,864
Market Cap Growth	-42.42%	-42.42%	-83.45%	-7.54%	23.39%	-
Enterprise Value	678	318	319	4,229	2,824	2,130
Last Close Price	1.60	0.97	1.63	9.85	12.30	10.46
PS Ratio	130.57	78.93	-	-	113.46	-
PB Ratio	2.22	1.34	1.45	2.61	2.35	2.16
P/TBV Ratio	4.50	2.72	2.14	3.10	2.74	2.51
EV/Sales Ratio	127.43	59.75	-	-	67.22	-
Debt / Equity Ratio	0.45	0.45	0.55	0.19	0.10	0.15
Asset Turnover	0.01	0.01	-	-	0.02	-
Quick Ratio	0.99	0.99	2.07	2.76	4.81	8.23
Current Ratio	1.03	1.03	2.10	4.74	6.94	8.39
Return on Equity (ROE)	-41.29%	-41.29%	-108.62%	-60.59%	-53.24%	-54.14%
Return on Assets (ROA)	-13.17%	-13.17%	-43.74%	-29.38%	-26.62%	-20.78%
Return on Capital (ROIC)	-16.01%	-16.01%	-51.30%	-33.68%	-29.44%	-23.10%
Earnings Yield	-23.79%	-39.35%	-160.22%	-24.48%	-21.68%	-15.62%
FCF Yield	-30.73%	-50.83%	-58.95%	-25.36%	-29.03%	-13.83%
Buyback Yield / Dilution	-0.39%	-0.39%	-13.94%	-5.66%	-15.21%	-29.24%

Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.